Cattedra di Semeiotica Medica 2 a and *Clinica Ostetrica e Ginecologica, University of Sassari, Viale San Pietro 12, 07100 Sassari, Italy
(Received 21 March 1977)
Recent evidence suggests that antioestrogens may interfere with secretion of prolactin. Tamoxifen inhibits oestrogen-induced release of prolactin in rats (Jordan, Koerner & Robison, 1975); furthermore, reduced levels of prolactin during fasting and blunted responses to synthetic thyrotrophin releasing hormone (TRH) have been reported in women with breast cancer undergoing treatment with tamoxifen (Willis, London & Butt, 1976). Another antioestrogen, clomiphene citrate, has been used with appreciable results to inhibit puerperal lactation (Zuckerman & Carmel, 1973; Weinstein, Ben-David & Polishuk, 1976), but it has no effect on the release of prolactin in normal man during fasting or hypoglycaemia, or after stimulation with synthetic TRH or sulpiride (Thomer, Besser, Hagen & McNeilly, 1974). We investigated the effect of clomiphene on the release of prolactin induced by mechanical
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 0 | 0 | 0 |
PDF Downloads | 1 | 0 | 0 |